WallStreetZenWallStreetZen

NASDAQ: CADL
Candel Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their CADL stock forecasts and price targets.

Forecast return on equity

Is CADL forecast to generate an efficient return?

Forecast return on assets

Is CADL forecast to generate an efficient return on assets?
Company
N/A
Industry
21.26%

CADL earnings per share forecast

What is CADL's earnings per share in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$0.91

CADL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CADL$6.02N/AN/A
OBIO$5.08$16.33+221.52%Strong Buy
CYBN$9.78$50.50+416.36%Strong Buy
PYXS$3.23$8.50+163.16%Strong Buy
BDTX$3.33$15.50+365.47%Strong Buy
View Top Biotech Stocks

Candel Therapeutics Stock Forecast FAQ

What is CADL's earnings growth forecast for 2024-2024?

(NASDAQ: CADL) Candel Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.83%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 20.1%.

Candel Therapeutics's earnings in 2024 is -$49,988,000.

In 2024, CADL is forecast to generate -$29,197,147 in earnings, with the lowest earnings forecast at -$29,197,147 and the highest earnings forecast at -$29,197,147.

If you're new to stock investing, here's how to buy Candel Therapeutics stock.

What is CADL's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: CADL) forecast ROE is N/A, which is considered weak.

What is CADL's Earnings Per Share (EPS) forecast for 2024-2024?

(NASDAQ: CADL) Candel Therapeutics's current Earnings Per Share (EPS) is -$1.69. In 2024, CADL's EPS is forecast to hit -$0.91 (min: -$0.91, max: -$0.91).

What is CADL's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: CADL) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 21.26%.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.